Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid

  • Taseera Kabanda
  • , Mark J. Siedner
  • , Jeffrey D. Klausner
  • , Conrad Muzoora
  • , David R. Boulware

Research output: Contribution to journalArticlepeer-review

106 Scopus citations

Abstract

The cryptococcal antigen (CRAG) lateral flow assay (LFA) had 100% sensitivity and specificity on cerebrospinal fluid samples. Pretreatment LFA titers correlated with quantitative cultures (R2 = 0.7) and predicted 2-and 10-week mortality. The CRAG LFA is an accurate diagnostic assay for CSF and should be considered for point-of-care diagnosis of cryptococcal meningitis.

Original languageEnglish (US)
Pages (from-to)113-116
Number of pages4
JournalClinical Infectious Diseases
Volume58
Issue number1
DOIs
StatePublished - Jan 1 2014

Bibliographical note

Funding Information:
Financial support. Research and salary support was provided by the NIAID (U01AI089244, K23AI073192, T32AI007433), the National Institute of Mental Health (K23099916), and the Medical Research Council (UK). Potential conflicts of interest. All authors: No reported conflicts.

Keywords

  • HIV
  • cryptococcal meningitis
  • diagnosis
  • point-of-care
  • sub-Saharan Africa

Fingerprint

Dive into the research topics of 'Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid'. Together they form a unique fingerprint.

Cite this